
### [MONDO:0018681](http://purl.obolibrary.org/obo/MONDO_0018681)
**Label:** neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome

**Subclasses:** [MONDO:0018131](http://purl.obolibrary.org/obo/MONDO_0018131) (neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to 9q21 microdeletion), [MONDO:0014700](http://purl.obolibrary.org/obo/MONDO_0014700) (neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to a point mutation), 

**Mapped go classes:** [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0008380](http://purl.obolibrary.org/obo/GO_0008380) (RNA splicing), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0000932](http://purl.obolibrary.org/obo/GO_0000932) (P-body), [GO:0032091](http://purl.obolibrary.org/obo/GO_0032091) (negative regulation of protein binding), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0003730](http://purl.obolibrary.org/obo/GO_0003730) (mRNA 3'-UTR binding), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0071013](http://purl.obolibrary.org/obo/GO_0071013) (catalytic step 2 spliceosome), [GO:0030628](http://purl.obolibrary.org/obo/GO_0030628) (pre-mRNA 3'-splice site binding), [GO:0045296](http://purl.obolibrary.org/obo/GO_0045296) (cadherin binding), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0010976](http://purl.obolibrary.org/obo/GO_0010976) (positive regulation of neuron projection development), [GO:0031072](http://purl.obolibrary.org/obo/GO_0031072) (heat shock protein binding), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:2000010](http://purl.obolibrary.org/obo/GO_2000010) (positive regulation of protein localization to cell surface), [GO:1902165](http://purl.obolibrary.org/obo/GO_1902165) (regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:2000173](http://purl.obolibrary.org/obo/GO_2000173) (negative regulation of branching morphogenesis of a nerve), [GO:0050806](http://purl.obolibrary.org/obo/GO_0050806) (positive regulation of synaptic transmission), [GO:0005681](http://purl.obolibrary.org/obo/GO_0005681) (spliceosomal complex), [GO:0060999](http://purl.obolibrary.org/obo/GO_0060999) (positive regulation of dendritic spine development), [GO:0000987](http://purl.obolibrary.org/obo/GO_0000987) (proximal promoter sequence-specific DNA binding), [GO:0021987](http://purl.obolibrary.org/obo/GO_0021987) (cerebral cortex development), [GO:0005521](http://purl.obolibrary.org/obo/GO_0005521) (lamin binding), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0043679](http://purl.obolibrary.org/obo/GO_0043679) (axon terminus), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0010988](http://purl.obolibrary.org/obo/GO_0010988) (regulation of low-density lipoprotein particle clearance), [GO:0048255](http://purl.obolibrary.org/obo/GO_0048255) (mRNA stabilization), [GO:0032993](http://purl.obolibrary.org/obo/GO_0032993) (protein-DNA complex), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:1903861](http://purl.obolibrary.org/obo/GO_1903861) (positive regulation of dendrite extension), [GO:1900273](http://purl.obolibrary.org/obo/GO_1900273) (positive regulation of long-term synaptic potentiation), [GO:0033120](http://purl.obolibrary.org/obo/GO_0033120) (positive regulation of RNA splicing), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0006417](http://purl.obolibrary.org/obo/GO_0006417) (regulation of translation), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0030529](http://purl.obolibrary.org/obo/GO_0030529) (intracellular ribonucleoprotein complex), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0048025](http://purl.obolibrary.org/obo/GO_0048025) (negative regulation of mRNA splicing, via spliceosome), [GO:0072369](http://purl.obolibrary.org/obo/GO_0072369) (regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0048260](http://purl.obolibrary.org/obo/GO_0048260) (positive regulation of receptor-mediated endocytosis), [GO:0051028](http://purl.obolibrary.org/obo/GO_0051028) (mRNA transport), [GO:1990829](http://purl.obolibrary.org/obo/GO_1990829) (C-rich single-stranded DNA binding), [GO:0090129](http://purl.obolibrary.org/obo/GO_0090129) (positive regulation of synapse maturation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0045716](http://purl.obolibrary.org/obo/GO_0045716) (positive regulation of low-density lipoprotein particle receptor biosynthetic process), [GO:0008298](http://purl.obolibrary.org/obo/GO_0008298) (intracellular mRNA localization), [GO:0042805](http://purl.obolibrary.org/obo/GO_0042805) (actinin binding), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:1904322](http://purl.obolibrary.org/obo/GO_1904322) (cellular response to forskolin), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007004](http://purl.obolibrary.org/obo/GO_0007004) (telomere maintenance via telomerase), [GO:0000723](http://purl.obolibrary.org/obo/GO_0000723) (telomere maintenance), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0006397](http://purl.obolibrary.org/obo/GO_0006397) (mRNA processing), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0001541](http://purl.obolibrary.org/obo/GO_0001541) (ovarian follicle development), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0019012](http://purl.obolibrary.org/obo/GO_0019012) (virion), [GO:0043021](http://purl.obolibrary.org/obo/GO_0043021) (ribonucleoprotein complex binding), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0019013](http://purl.obolibrary.org/obo/GO_0019013) (viral nucleocapsid), [GO:1990715](http://purl.obolibrary.org/obo/GO_1990715) (mRNA CDS binding), [GO:0051117](http://purl.obolibrary.org/obo/GO_0051117) (ATPase binding), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [GO:0019013](http://purl.obolibrary.org/obo/GO_0019013) (viral nucleocapsid) 52.27%
- [GO:0019012](http://purl.obolibrary.org/obo/GO_0019012) (virion) 52.27%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 52.27%
- [GO:0044423](http://purl.obolibrary.org/obo/GO_0044423) (virion part) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 37.63%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 37.63%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.63%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.63%


